Joseph G. Marano
Lawyers
Filters
Mirion Technologies acquisition of Sun Nuclear and related financing
We advised Mirion on the acquisition and incremental term loan credit facility
Five Prime Therapeutics $173 million follow-on offering
Davis Polk advised the joint-bookrunning managers and representatives of the several underwriters in connection with an approximately $173.8 million public offering of common stock by…
iRhythm Technologies $220 million stock offering
Davis Polk advised the joint book-running managers and representatives of the several underwriters in connection with an SEC-registered offering of common stock by iRhythm Technologies…
Horizon Therapeutics $963.5 million share offering
Davis Polk advised the representatives of the underwriters in connection with an approximately $963.5 million public offering of ordinary shares of Horizon Therapeutics Public Limited…
II-VI Incorporated $920 million common stock and convertible preferred offerings
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by II-VI Incorporated of 10,697,570 shares of its common stock for an…
Shockwave Medical $89.4 million stock offering
Davis Polk advised Shockwave Medical, Inc. on its SEC-registered public offering of 1,955,000 shares of common stock for an aggregate price to the public of approximately $89.4 million,…
Amazon.com $10 billion notes offering
Davis Polk advised the joint book-running managers in connection with a $10 billion SEC-registered debt offering by Amazon.com, Inc., consisting of $1 billion of its 0.400% notes due…
1Life Healthcare $275 million convertible senior notes offering
Davis Polk advised the joint book-running managers and representatives of the initial purchasers in connection with a Rule 144A offering by 1Life Healthcare, Inc. of $275 million…
Applied Materials $1.5 billion notes offering
Davis Polk advised the underwriters in connection with an SEC-registered offering by Applied Materials, Inc. of $750 million aggregate principal amount of its 1.750% notes due 2030 and $750…
NeoGenomics $300 million offerings of stock and convertible senior notes
Davis Polk advised the joint book-running managers in connection with concurrent SEC-registered offerings by NeoGenomics, Inc. of 4,400,000 shares of its common stock and $175 million…